Singapore manufacturing defies odds in January
- 26 February 2020
- Singapore
While manufacturing data was a pleasant upside surprise, we would caution against any exuberance as the spread of the coronavirus could dent activity in February and the months to come
| 3.4% |
January manufacturing growthyear-on-year |
| Higher than expected | |
A surprising manufacturing bounce
Singapore’s January manufacturing data caught the consensus, which was centred on a 5.8% year-on-year fall, on the wrong footing. Instead, output surged by 3.4%, defying the unfavourable base year effect as well as continued weak non-oil domestic exports in January. The outbreak of Covid-19 was another factor behind the expectations for a weaker reading.
A seasonally-adjusted 18.2% monthly bounce, on top of a 6.3% rise in December (revised up from 4.1% initial estimate) also contrasts with the expectation of a decline. This could be surmised as either front-loading ahead of the Lunar New Year holiday or a positive response to the phase one trade deal between China and the US. On the flip-side, it probably did not capture the impact of an extended post-holiday slump due to the Covid-19 outbreak.
59% surge in pharma explains it all
Unsurprisingly though, just as the coronavirus emerged as a serious health emergency, the pharmaceutical sector kicked into high gear. Indeed, it was the main source of overall manufacturing strength with a 59% year-on-year (78% month-on-month unadjusted) leap in output. Growth in all the other main manufacturing sectors, except precision engineering, remained in negative territory.
An 18% surge in engineering may reflect the delivery of ongoing projects, while the sector has yet to succumb to the broader slack elsewhere. And, electronics was a mixed bag in January with continued weak exports, yet a bit firmer output.
But it failed to cheer markets
While this was a pleasant upside surprise, it failed to cheer the markets - the Strait Times Index of stock prices remained in the red and the Singapore dollar was little moved. Investors are likely pricing in more disappointing data ahead.
The risk of this entire bounce being reversed in February can’t be ignored in light of prolonged slack due to the spread of the virus this month. The combined January-February growth will remove the Lunar New Year impact and also act as an initial gauge of the impact of the disease that’s now spreading beyond Asia.
We continue to see a likelihood of the economy sliding into a recession in the first half of the year, before accelerated fiscal policy support, and possibly an easing by the Monetary Authority of Singapore in April helps the recovery over the rest of the year.
Content Disclaimer
This publication has been prepared by ING solely for information purposes irrespective of a particular user's means, financial situation or investment objectives. The information does not constitute investment recommendation, and nor is it investment, legal or tax advice or an offer or solicitation to purchase or sell any financial instrument.Read more
Included in the following bundle
Good MornING Asia - 27 February 2020
- This bundle contains 3 Articles